Brazilian Journal of Anesthesiology (May 2013)

Influence of Hypnotics on Cisatracurium-induced Neuromuscular Block. Use of Acceleromyograhpy

  • Angélica de Fátima de Assunção Braga,
  • Franklin Sarmento da Silva Braga,
  • Glória Maria Braga Potério,
  • José Aristeu Fachini Frias,
  • Fernanda Maria Silva Pedro,
  • Derli Conceição Munhoz

Journal volume & issue
Vol. 63, no. 3
pp. 249 – 253

Abstract

Read online

Background and objective: : Different drugs, including hypnotics, may influence the pharmacodynamic effects of neuromuscular blockers (NMB). The aim of this study was to evaluate the influence of propofol and etomidate on cisatracurium-induced neuromuscular blockade. Method: We included 60 patients, ASA I and II, undergoing elective surgery under general anesthesia in the study and randomly allocated them into two groups, according to their hypnotic drug: GI (propofol) and GII (etomidate). Patients received intramuscular (IM) midazolam (0.1 mg.kg-1) as premedication and we performed induction with propofol (2.5 mg.kg-1) or etomidate (0.3 mg.kg-1), preceded by fentanyl (250 mg) and followed by cisatracurium (0.1 mg.kg-1). The patients were ventilated with 100% oxygen until obtaining a reduction of 95% or more in the adductor pollicis response amplitude, with subsequent laryngoscopy and tracheal intubation. Neuromuscular function was monitored by acceleromyograhpy. We evaluated the onset of action of cisatracurium, tracheal intubation conditions, and hemodynamic repercussions. Results: The mean time and standard deviations of cisatracurium onset were: GI (86.6 ± 14.3 s) and GII (116.9 ± 11.6 s), with a significant difference (p < 0, 0001). Intubation conditions were acceptable in 100% of GI and 53.3% of GII patients (p < 0.0001). Conclusion: Induction of neuromuscular blockade with cisatracurium was faster, with better intubation conditions in patients receiving propofol compared to those receiving etomidate, without hemodynamic repercussions. Keywords: Hypnotics and Sedatives, Propofol, Etomidate, Neuromuscular blockade/cisatracurium, Monitoring, Physiologic.